
Madrigal Pharmaceuticals (MDGL)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Madrigal Pharmaceuticals (MDGL) Stock
Start investing in Madrigal Pharmaceuticals (MDGL)
About Madrigal Pharmaceuticals (MDGL)
Market cap | $6.72B |
Yesterday's volume | 20 |
Revenue (TTM) | $317.38M |
Avg. daily volume | 344.03K |
EBITDA (TTM) | -$423.84M |
Open | $303.09 |
Price / earnings ratio | -16.77x |
Yesterday's range | $299.21 - $308.92 |
Debt / equity | 16.85x |
52 week range | $200.63 - $377.46 |
5 year debt / equity | 13.97x |
Beta (LTM) | 0.9x |
Interest coverage | -33.94x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 5.91x |
Ex-dividend date | — |
Next earnings | Aug 6, 2025 |
Dividend payable date | — |
Madrigal Pharmaceuticals Stock Rating
Madrigal Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy MDGL stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in MDGL stock
Navigate to the Explore page. Then, type MDGL into the search bar. When you see MDGL stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased MDGL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Madrigal Pharmaceuticals Stock Earnings
The value each MDGL share was expected to gain vs. the value that each MDGL share actually gained.
Madrigal Pharmaceuticals (MDGL) reported Q1 2025 earnings per share (EPS) of -$3.32, beating estimates of -$3.79 by 12.40%. In the same quarter last year, Madrigal Pharmaceuticals's earnings per share (EPS) was -$7.38. Madrigal Pharmaceuticals is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of -$3.65.